Non-invasive radiogenomic assessment of growth-associated protein 43 in lung adenocarcinoma brain metastases.
GAP43 is an adverse prognostic biomarker in LUAD brain metastases and a CE-T1WI radiogenomic model accurately predicts GAP43 expression, facilitating individualized short-term survival stratification.